| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0042 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.009 | 1 |